Cargando…
Thrombolysis with reteplase in acute pulmonary embolism
OBJECTIVE: Reteplase (recombinant plasminogen activator) is a mutant of alteplase. It has a longer half-life than its parent molecule and has shown better vessel patency rates in acute myocardial infarction. In this study, we analyzed the efficacy and safety of reteplase in acute pulmonary embolism...
Autores principales: | Nishanth, K.R., Math, Ravi S., Shankar, Mythri, Ravindranath, K.S., Manjunath, C.N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136336/ https://www.ncbi.nlm.nih.gov/pubmed/32248919 http://dx.doi.org/10.1016/j.ihj.2019.09.011 |
Ejemplares similares
-
National Heart Failure Registry, India: Design and methods
por: Harikrishnan, Sivadasanpillai, et al.
Publicado: (2019) -
Epidemiological trends of acute coronary syndrome in Shimla district of the hilly state of Northern India: Six-year data from the prospective Himachal Pradesh acute coronary syndrome registry
por: Chand Negi, Prakash, et al.
Publicado: (2019) -
Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and meta-analysis
por: Goel, Sunny, et al.
Publicado: (2019) -
9p21.3 coronary artery disease risk locus and interferon alpha 21: Association study in an Asian Indian population
por: Kalpana, Bellary, et al.
Publicado: (2019) -
To study the usefulness and comparison of myocardial strain imaging by 2D and 3D echocardiography for early detection of cardiotoxicity in patients undergoing cardiotoxic chemotherapy
por: Alam, Shamshad, et al.
Publicado: (2019)